Eli Lilly wins UK Alimta drug patent case on appeal, shares jump

LONDON (Reuters) - Eli Lilly has won a patent case in the Court of Appeal in London over its blockbuster Alimta lung cancer drug, boosting prospects for future sales and dealing a blow to generic challenger Actavis, now renamed Allergan.

Source: Reuters: Health - June 25, 2015 Category: Consumer Health News Tags: healthNews Source Type: news